Xovoltib 20 Mg

Xovoltib 20 Mg

Xovoltib 20 Mg is a targeted anticancer medication used in the treatment of non-small cell lung cancer (NSCLC), particularly in patients with specific epidermal growth factor receptor (EGFR) mutations. It contains afatinib, a tyrosine kinase inhibitor (TKI) that blocks signals responsible for cancer cell growth and proliferation. This lower-strength formulation is often used for initial therapy or dose adjustments based on patient tolerance. In treatment planning, higher strengths such as Xovoltib 30 Mg and Xovoltib 40 Mg are commonly prescribed depending on clinical response and disease severity.

Mechanism of Action

EGFR Inhibition

Xovoltib 20 Mg works by irreversibly blocking EGFR and related receptors, which are involved in the growth and spread of cancer cells.

Targeted Cancer Therapy

By inhibiting these pathways, it prevents tumor cell proliferation and promotes cancer cell death. For detailed clinical insights, refer to National Cancer Institute (NCI) and for safety information, consult Mayo Clinic – Afatinib Drug Information.

Medical Uses

Xovoltib 20 Mg is used in:

• EGFR mutation-positive non-small cell lung cancer (NSCLC)
• Advanced or metastatic lung cancer

It is often prescribed as a first-line treatment in eligible patients.

Dosage and Administration

Xovoltib 20 Mg is typically taken once daily on an empty stomach, as directed by an oncologist. The dosage may be adjusted based on patient response and side effects. In clinical practice, Xovoltib 30 Mg may be used for intermediate dosing, while Xovoltib 40 Mg is commonly prescribed as a standard dose in suitable patients.

Clinical Effectiveness

Clinical studies have shown that afatinib significantly improves progression-free survival in patients with EGFR mutation-positive NSCLC. It is considered an effective targeted therapy in modern oncology.

Safety and Side Effects

Common Side Effects

• Diarrhea
• Skin rash
• Mouth sores
• Nail changes

Serious Risks

• Severe diarrhea and dehydration
• Lung inflammation (interstitial lung disease)
• Liver toxicity

Regular monitoring is essential during treatment. For more details, refer to Mayo Clinic – Afatinib Drug Information.

Contraindications and Precautions

Xovoltib 20 Mg should be used with caution in:

• Patients with lung disorders
• Individuals with liver impairment
• Patients with severe gastrointestinal issues

It should not be used during pregnancy unless prescribed.

Drug Interactions

Xovoltib 20 Mg may interact with medications affecting liver enzymes and other anticancer drugs. Patients should inform their healthcare provider about all medications they are taking. For research-based insights, refer to National Cancer Institute (NCI).

FAQs